🇺🇸 FDA
Patent

US 6858652

Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them

expired A61PA61P25/00A61P25/24

Quick answer

US patent 6858652 (Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Feb 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P25/00, A61P25/24